Society RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with OpaganibBy Business News AsiaNovember 19, 20200 RedHill Biopharma Ltd (Nasdaq: RDHL), a specialty biopharmaceutical company, today announced that the U.S. Phase 2 study with opaganib (Yeliva®,…
